Your browser doesn't support javascript.
loading
Treatment strategies in patients with AML or high-risk myelodysplastic syndrome relapsed after Allo-SCT.
Sauer, T; Silling, G; Groth, C; Rosenow, F; Krug, U; Görlich, D; Evers, G; Albring, J; Besoke, R; Mesters, R M; Müller-Tidow, C; Kessler, T; Büchner, T; Berdel, W E; Stelljes, M.
Affiliation
  • Sauer T; Department of Internal Medicine A, Hematology and Oncology, University of Muenster, Muenster, Germany.
  • Silling G; Department of Internal Medicine A, Hematology and Oncology, University of Muenster, Muenster, Germany.
  • Groth C; Department of Internal Medicine A, Hematology and Oncology, University of Muenster, Muenster, Germany.
  • Rosenow F; Department of Internal Medicine A, Hematology and Oncology, University of Muenster, Muenster, Germany.
  • Krug U; Department of Internal Medicine A, Hematology and Oncology, University of Muenster, Muenster, Germany.
  • Görlich D; Institute of Biostatistics and Clinical Research, University of Muenster, Muenster, Germany.
  • Evers G; Department of Internal Medicine A, Hematology and Oncology, University of Muenster, Muenster, Germany.
  • Albring J; Department of Internal Medicine A, Hematology and Oncology, University of Muenster, Muenster, Germany.
  • Besoke R; Institute of Human Genetics, University of Muenster, Muenster, Germany.
  • Mesters RM; Department of Internal Medicine A, Hematology and Oncology, University of Muenster, Muenster, Germany.
  • Müller-Tidow C; 1] Department of Internal Medicine A, Hematology and Oncology, University of Muenster, Muenster, Germany [2] Department of Medicine IV, Hematology and Oncology, University of Halle, Halle, Germany.
  • Kessler T; Department of Internal Medicine A, Hematology and Oncology, University of Muenster, Muenster, Germany.
  • Büchner T; Department of Internal Medicine A, Hematology and Oncology, University of Muenster, Muenster, Germany.
  • Berdel WE; Department of Internal Medicine A, Hematology and Oncology, University of Muenster, Muenster, Germany.
  • Stelljes M; Department of Internal Medicine A, Hematology and Oncology, University of Muenster, Muenster, Germany.
Bone Marrow Transplant ; 50(4): 485-92, 2015 Apr.
Article in En | MEDLINE | ID: mdl-25599163
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myelodysplastic Syndromes / Leukemia, Myeloid, Acute / Salvage Therapy / Hematopoietic Stem Cell Transplantation Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Bone Marrow Transplant Year: 2015 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myelodysplastic Syndromes / Leukemia, Myeloid, Acute / Salvage Therapy / Hematopoietic Stem Cell Transplantation Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Bone Marrow Transplant Year: 2015 Document type: Article